India to Australia: Lenalidomide Export Trade Route

The India to Australia Lenalidomide corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $1.1M USD. The route is dominated by CIPLA LIMITED , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $95.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 28.0%, placing it at rank #10 among India's top lenalidomide export destinations globally.

On the import side, key buyers of Indian lenalidomide in Australia include CIPLA AUSTRALIA PTY LTD , XXlanXXrelXXd LXXiteXX NeXXnhaXXCouXX MXXahiXX Ro. CIPLA AUSTRALIA PTY LTD is the single largest importer with 10 shipments valued at $1.0M USD.

India's lenalidomide exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED , MYLAN LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $95.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cipla lenalidomide 15mg capsules (lenali and cipla lenalidomide 5mg capsules (lenalid , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA AUSTRALIA PTY LTD is the largest importer with 10 shipments worth $1.0M USD — representing 100% of all lenalidomide imports from India on this route.